TOYOTA GAZOO Racing and MoneyGram Haas F1 Team Agree on Technical Partnership for the Future of the Automotive Industry

Toyota City, Japan, Oct 11, 2024 - (JCN Newswire via SeaPRwire.com) - TOYOTA GAZOO Racing (TGR) and MoneyGram Haas F1 Team announced today that they have concluded a basic agreement on entering a technical partnership concerning MoneyGram Haas F1 Team vehicle development and collaborative efforts. Through this partnership, the two…

Oita University and Hitachi High-Tech Give a Joint Presentation on the Use of AI Technology to Extend the Lifespan of Polymer Electrolyte Fuel Cells

TOKYO, Oct 11, 2024 - (JCN Newswire via SeaPRwire.com) - National University Corporation OITA UNIVERSITY ("Oita University") and Hitachi High-Tech Corporation ("Hitachi High-Tech") today announced that we have started conducting research ("this research") into predicting and extendingthe life of electrocatalysts used in polymer electrolyte fuel cells (PEFC), utilizing Hitachi High-Tech’s…

25th BFSI Summit 2024: Leading the Future of Financial Services in South Africa

South Africa's BFSI business is rapidly expanding, driven by innovation and technology to improve service delivery and efficiency, as demonstrated by a leading banking institution that has successfully deployed over 100 robotic process automation (RPA) robots to automate a variety of operations.This initiative has significantly increased efficiency while highlighting challenges…

InLine Aviation Group Launches Comprehensive Maintenance and Support Program: UpAssist™

WHITE PLAINS, N.Y., Oct. 7, 2024 — UpAssist by InLine Aviation Group introduces a comprehensive maintenance and support program for general aviation aircraft. This innovative program provides Aircraft on Ground (AOG) assistance worldwide, parts procurement, 24/7 technical support, records management, quality control & oversight, supplemental air charter, and much more.…

Alzamend Neuro CEO Stephan Jackman to Speak at Maxim Group’s Virtual Healthcare Conference

ATLANTA–October 10, 2024– (NASDAQ:ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today announced that CEO Stephan Jackman will participate in a fireside chat at the upcoming Maxim Group…